Apsito Tablet 20 mg (Fexuprazan Hydrochloride)

Adult dose

Prevention of nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcers (gastric and duodenal ulcers) Administer 20mg orally once daily for 24 weeks. The duration of the comparative clinical trial did not exceed 24 weeks. This medicine may be administered without regard to meals.

This medication should not be used in patients with allergic reactions or those who have been sensitive to any of its ingredients in the past. Additionally, patients taking certain antiviral medications and pregnant or breastfeeding women should avoid this medication. Patients with genetic metabolic disorders such as lactose intolerance should also avoid this medication. Special caution is required when this medication is used in patients with poor liver or kidney function. Elderly patients should be cautious when taking this medication due to diminished bodily functions. Patients should be aware that side effects such as gastrointestinal disturbances, diarrhea, and abdominal pain may occur while taking this medication. The risk of osteoporosis may increase with long-term use, so the medication should be taken at the minimum dose for the necessary duration. Regular blood tests may be needed if magnesium levels decrease due to long-term use or use alongside certain medications. This medication reduces gastric acid, which may slightly increase the risk of bacterial infections in the stomach, so if diarrhea persists, medical consultation should be sought. It is used for the prevention of gastric ulcers in patients taking non-steroidal anti-inflammatory drugs (NSAIDs), and gastric conditions must be verified before administration. This medication may interact with other drugs, so any medications currently being taken should be disclosed. Pregnant and breastfeeding women should avoid this medication, as its safety during pregnancy has not been confirmed. Safety for children and adolescents has not been established, so its use is not recommended. This medication should be kept out of reach of children, and transferring it to another container may affect its quality.

• Dyspepsia
• diarrhea
• erosive gastritis
• upper abdominal pain
• nausea
• abdominal discomfort
• vomiting
• abdominal distension
• constipation
• enteritis

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This will help preserve the effectiveness of the medication for a longer period.

Appearance

Pale yellow rectangular film-coated tablet

Package unit

28 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle, 28 tablets/box [7 tablets/PTPx4]